{Reference Type}: Journal Article
{Title}: Polydeoxyribonucleotides Pre-Clinical Findings in Bone Healing: A Scoping Review.
{Author}: Manfredini M;Poli PP;Beretta M;Pellegrini M;Salina FE;Maiorana C;
{Journal}: Dent J (Basel)
{Volume}: 11
{Issue}: 12
{Year}: 2023 Dec 4
暂无{DOI}: 10.3390/dj11120280
{Abstract}: <B>OBJECTIVE: </B>Polydeoxyribonucleotide (PDRN) is a chain-like polymer derived from DNA. Recent in vitro and animal studies have showcased the beneficial impacts of PDRN on the process of bone mending, whether used on its own or in conjunction with other substances that aid in regeneration. This scoping review aims to synthesize the current understanding of how PDRNs influence bone healing.<BR><B>METHODS: </B>The studies included in the screening procedure were randomized controlled clinical trials (RCTs), both retrospective and prospective case-control studies, as well as in vitro and in vivo investigations. Articles were sourced from PubMed (MEDLINE), Scopus, EMBASE, Web of Science, and Google Scholar electronic databases using the following MeSH terms: (polydeoxyribonucleotide) and (bone) and (regeneration).<BR><B>RESULTS: </B>Initially, 228 articles were identified. Following the review process, a total of eight studies were ultimately examined. Among these, two were confined to laboratory studies, five were conducted on living organisms, and one encompassed both evaluations on living organisms and in vitro assessments. A descriptive qualitative approach was employed to present the data extracted from the studies that were included.<BR><B>CONCLUSIONS: </B>PDRN has the potential to enhance the process of bone healing and the quantity of newly generated bone when combined with grafting materials. Future clinical studies are warranted to ascertain the appropriate clinical application of PDRN based on the dosage under consideration.